background: cardiovascular diseases are viewed worldwide as one of the main causes of death.this study aims to report the burden of ischemic heart diseases (ihds) in iran by using data of the global burden of disease (gbd) study, 1990-2010. materials and methods: the gbd study 2010 was a systematic eff ort to provide comprehensive data to calculate disability-adjusted life years (dalys) for dis...

BACKGROUND The health impacts of pulmonary impairment after tuberculosis (TB) treatment have not been included in assessments of TB burden. Therefore, previous global and national TB burden estimates do not reflect the full consequences of surviving TB. We assessed the burden of TB including pulmonary impairment after tuberculosis in Tarrant County, Texas using Disability-adjusted Life Years (D...

background: accidents are the second cause of death in iran and one of the significant challenges in public health. they can affect people in all ages. in this study, we try to calculate years of life lost due to intentional and unintentional injuries, which is considered as one of the main indicators for prioritizing public health problems.   methods: this study is a practical cross sectional ...

BACKGROUND Gastrointestinal and liver diseases (GILD) constitute a noteworthy portion of causes of death and disability in Iran. However, data on their prevalence and burden is sparse in Iran. The Global Burden of Disease (GBD) study in 2010 has provided invaluable comprehensive data on the burden of GILD in Iran. METHODS Estimations of death, years of life lost due to premature death (YLL), ye...

Assessing the health situation in populations has traditionally been carried out on the basis of mortality data, and where available, on the prevalence and/or incidence of disease. A new approach to quantifying the burden of disease has been developed which simultaneously considers both premature death as well as the non-fatal health consequences of disease and injury. The burden of disease app...

OBJECTIVES The burden of epilepsy, in terms of both morbidity and mortality, is likely to vary depending on the etiology (primary [genetic/unknown] vs. secondary [structural/metabolic]) and with the use of antiepileptic drugs (AEDs). We estimated the disability-adjusted life years (DALYs) and modeled the remission rates of active convulsive epilepsy (ACE) using epidemiologic data collected over...